Filter Results:
(3,421)
Show Results For
- All HBS Web
(3,421)
- People (9)
- News (721)
- Research (2,192)
- Events (38)
- Multimedia (28)
- Faculty Publications (1,298)
Show Results For
- All HBS Web
(3,421)
- People (9)
- News (721)
- Research (2,192)
- Events (38)
- Multimedia (28)
- Faculty Publications (1,298)
Arthur C. Dorrance
phenomenal success. The Campbell Test Kitchen opened in 1940, and under Dorrance’s leadership, Campbell home economists developed recipes using condensed soups, many of which have become classics. View Details
Keywords: Food & Tobacco
- 03 Apr 2016
- News
The Tampon of the Future
2009), an entrepreneur with an engineering background. “I was trying to develop a way for women to monitor their own fertility at home,” she told the New York Times recently. “Those kinds of diagnostic tests require a lot of blood. So I... View Details
- 2023
- Working Paper
Market Exclusivity and Innovation: Evidence From Antibiotics
By: Edward Kong and Olivia Zhao
The US incentivizes drug innovation via patents as well as market exclusivity periods awarded by the US Food and Drug Administration. We estimate the causal effects of extending market exclusivity for an important drug class: antibiotics. Using a... View Details
Keywords: Health Testing and Trials; Innovation and Invention; Motivation and Incentives; Government Administration; Government Legislation; Pharmaceutical Industry; United States
Kong, Edward, and Olivia Zhao. "Market Exclusivity and Innovation: Evidence From Antibiotics." Working Paper, December 2023.
- 15 Jun 2020
- Research & Ideas
A Mass Crisis Can Overwhelm Health Care. Liberia Found a Solution.
test people, then process the tests and take them to a waiting area.” When Ebola began ravaging the country in 2014, Liberia’s government came knocking on Last Mile Health’s door. The organization helped the... View Details
- Web
Frequently Asked Questions | MBA
Frequently Asked Questions MD / MBA If I am interested in pursuing the MD/MBA Program, when do I apply? When should I take the GMAT or GRE? Is one test preferred over the other? Is there a target test score?... View Details
- 23 Jan 2019
- News
The Promise of Personalized Medicine
be able to do computational prediction for creating a top 20 list of antisense oligos. With those, we can test them against his cell line. So as part of the biopsy, in phase one, we establish a cell line. What that is, is it’s taking... View Details
- 01 Sep 2018
- News
The True Value of a Tweet
will actually say something, and the rest is the silent majority. So if you’re an executive, how do you pin a value to this tool? LJ: There has to be a more careful study of that. But all of these digital tools are amazing for marketers and have enhanced our capability... View Details
Keywords: Jen McFarland Flint
- 12 Nov 2015
- Research & Ideas
Can Consumers be Trusted with Their Own Health Care?
and a profile that varies by situation and according to the patient’s life stage.” Patient Empowerment Taken Too Far? As an example of patient empowerment—and a glimpse at its potential problems—Quelch talked about taking the 23andMe test, a saliva-based... View Details
- Web
Comparison of Output with Hours of Sleep – The Human Relations Movement – Baker Library, Historical Collections
HBS Home HBS Index Contact Us Back to Exhibit Page Comparison of Output with Hours of Sleep First Relay Assembly Test Group, ca. 1930 Western Electric Company Hawthorne Studies Collection © 2007 President and Fellows of Harvard College;... View Details
- Web
They keep the milk cool - The Human Factor – Baker Library | Bloomberg Center, Historical Collections
The Message The Product The Production The Worker The Audience Bibliography previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 next They keep the milk cool ca. 1933 Kraft–Phenix Cheese Corporation Photographer unknown Two of the large, glass-lined, brine-cooled... View Details
- Web
Success Academy Charter Schools | Information Technology
Development and Research test caption Previous test caption Previous Next test caption Previous Next More Featured Cases The Reinvention of Kodak Professor Ryan Raffaelli, Dave... View Details
- 17 Jun 2020
- News
Toronto Copes with COVID-19 Via Webinars; Alumni Respond to Pandemic in Philippines
testing in Canada, and how Canadian hospitals handled surges and so on,” says club president Kazi Ahmed “It was a great opportunity for our club to strengthen our relationship with the Cleveland Clinic.” According to the club’s board... View Details
Keywords: Margie Kelley
- January 2023
- Case
Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery
By: Regina Herzlinger and Brian Walker
What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful... View Details
Keywords: Product Development; Leadership; Health Testing and Trials; Research and Development; Risk and Uncertainty; Financial Condition; Partners and Partnerships; Pharmaceutical Industry
Herzlinger, Regina, and Brian Walker. "Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery." Harvard Business School Case 323-045, January 2023.
- February 2009
- Case
Avid Radiopharmaceuticals: The Venture Debt Question
By: Matthew Rhodes-Kropf and Ann Leamon
The CEO of a promising biotech company must decide how to respond to the macro-economic slump of late 2008. He had planned to pursue an aggressive schedule, moving the firm's Alzheimer's and Parkinson's disease imaging compounds through clinical trials and into the... View Details
Keywords: Financial Crisis; Entrepreneurship; Borrowing and Debt; Venture Capital; Financial Management; Investment; Health Testing and Trials; Expansion; Biotechnology Industry; Pharmaceutical Industry
Rhodes-Kropf, Matthew, and Ann Leamon. "Avid Radiopharmaceuticals: The Venture Debt Question." Harvard Business School Case 809-086, February 2009.
- 01 Dec 2011
- News
Research With Impact: Changing Global Health Practices
Professor Ashraf (center) with members of the study implementation team at Chipata Clinic, Lusaka, Zambia, including fi eld managers, surveyors, community health workers, and a study nurse. (click for larger view) Read a summary of Ashraf's recent presentation at HBS... View Details
- 18 Mar 2001
- Research & Ideas
The Essentials for Enlightened Experimentation
incentives to encourage rapid experimentation. Consider using small development groups that contain key people (designers, test engineers, manufacturing engineers) with all the knowledge required to iterate rapidly. Determine what... View Details
Keywords: by Stefan Thomke
- Web
Launch Lab/Capstone 1 - Course Catalog
system engineering methods to plan, design, develop, build, and test a complex technology-based product/service, integrating knowledge across multiple engineering disciplines. Business Knowledge: The use of business model analysis and... View Details
- February 2020
- Teaching Note
Theranos: Who Has Blood on Their Hands? (A) and (B)
By: Nien-he Hsieh and Christina R. Wing
Teaching Note for HBS Nos. 619-039 and 320-091. View Details
- November 2009 (Revised March 2010)
- Case
Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story
By: Richard G. Hamermesh, Raju Kucherlapati and Rachel Gordon
In May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had... View Details
Keywords: Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Marketing Strategy; Product Positioning; Genetics; Biotechnology Industry; Europe; United States
Hamermesh, Richard G., Raju Kucherlapati, and Rachel Gordon. "Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story." Harvard Business School Case 810-066, November 2009. (Revised March 2010.)
- Portrait Project
Lindsay Rosenblum
understanding of my “learning disability” morphed into a deep, irrational belief that I was a fraud, had cheated the system, and fooled the tester not just that day in 2002, but when I was tested again in 2006, 2010, and 2014. I don’t... View Details